Last updated: October 10, 2019
Sponsor: Central Hospital, Nancy, France
Overall Status: Active - Recruiting
Phase
N/A
Condition
Allo-hematopoietic Stem Cell Transplant
Allogeneic Hematopoietic Stem Cell Transplant
Treatment
N/AClinical Study ID
NCT03357172
2018-A03267-48
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
patient of the Nancy CHRU, for whom a CSH allograft is planned. or
hematopoietic stem cell donors received at Nancy's CHRU for the duration of theresearch
Exclusion
Exclusion Criteria:
Positive HIV
active hepatitis B or C infection
Study Design
Total Participants: 700
Study Start date:
October 01, 2019
Estimated Completion Date:
September 30, 2026
Connect with a study center
CHRU de Nancy
Vandoeuvre Les Nancy, 54511
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.